Oncology

Test Code: 13808 to be added to 6399

Breast Plus Panel without BRCA (TP53, STK11, PTEN, CDH1, PALB2)

Test Code: 92586

CPT Code(s): 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479

Clinical Significance: CDH1, PALB2, PTEN, STK11 and TP53 are tumor suppressor genes, where inherited mutations significantly increase breast cancer risk. Sequence analysis and deletion/duplication analysis of these five genes can explain an additional 3% to 4.5% of hereditary breast cancers.

Test Code: 92573

CPT Code(s): 81162

Includes: If the Interpretation Summary is not one of the following three results: Positive for a known Pathogenic Mutation; Positive for a likely Pathogenic Mutation; Positive for a likely Pathogenic Mutation and a variant with unknown significance, then TP53, PTEN, CDH1, STK11, and PALB2 will be performed at an additional charge (CPT code(s) 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479).

Wall Charts can be ordered by emailing DLOClientSupply@questdiagnostics.com or you can download/print the chart by clicking on the disc or printer icon above the chart below:

Test Code: 7210

CPT Code(s): 85004, 85014, 85018, 85041, 85048

Clinical Significance: A complete blood count is used as a screening test for various disease states including anemia, leukemia and inflammatory processes.

Test Code: 7008

CPT Code(s): 85014, 85018, 85041, 85048 (HCPCS: G0307)

Clinical Significance: A complete blood count used as a screening test for various disease states to include: Anemia, leukemia and inflammatory processes.

Includes: WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW

Test Code: 6399

Test Code: 7998

Test Code: 11290 (Non Medicare); 11293 (Medicare)

CPT Code(s): 82274 (HCPCS:G0328)